BackFulgent Genetics Overview

Fulgent Genetics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for FLGT.

Quarterly EBIT

-$34.62M
94.31% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$91.21M
51.71% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)